Hill R P
Department of Clinical Chemistry, King's Mill Hospital, Sutton-in-Ashfield, Nottinghamshire, UK.
Ann Clin Biochem. 1988 Jul;25 ( Pt 4):435-9. doi: 10.1177/000456328802500422.
Human pooled serum from diabetic and non-diabetic subjects, and calibrators containing glycated protein or 1-deoxy-1-morpholinofructose (DMF) in a variety of matrices, were distributed to 10 laboratories. When they used their own assay conditions and calibrators, the inter-laboratory variation was unacceptably high. However, when the pool from diabetic patients was reassayed using a calibrator with an assigned value prepared from freeze-dried human serum, and containing no DMF, inter-laboratory variation was reduced significantly. Inter-laboratory agreement for the pool from non-diabetic subjects remained poor despite recalibration. Recalibration using either serum or albumin based solutions of DMF as calibrator failed to effect any significant reductions in inter-laboratory variation. Secondary calibrators based on a protein matrix with no added DMF are recommended for routine use.
来自糖尿病和非糖尿病受试者的人混合血清,以及包含糖化蛋白或1-脱氧-1-吗啉果糖(DMF)的各种基质校准品,被分发给了10个实验室。当他们使用自己的检测条件和校准品时,实验室间差异高得令人无法接受。然而,当使用由冻干人血清制备且不含DMF的指定值校准品对糖尿病患者的混合血清进行重新检测时,实验室间差异显著降低。尽管重新校准,非糖尿病受试者混合血清的实验室间一致性仍然很差。使用基于血清或白蛋白的DMF溶液作为校准品进行重新校准未能显著降低实验室间差异。建议常规使用基于无添加DMF的蛋白质基质的二级校准品。